Jane Street’s Aligos Therapeutics ALGS Stock Holding History

Jane Street’s Portfolio ALGS Stock Details ALGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$187K	Buy	+32,402	New	+$200K	﹤0.01%	10176
2026 Q1	–	Sell	-24,293	Closed	-$226K	–	11462
2025 Q4	$226K	Buy	+24,293	New	+$229K	﹤0.01%	9471
2024 Q3	–	Sell	-547	Closed	-$4.78K	–	9507
2024 Q2	$4.78K	Buy	+547	New	+$9.62K	﹤0.01%	9167
2023 Q2	–	Sell	-1,050	Closed	-$22.9K	–	8605
2023 Q1	$22.9K	Buy	1,050 +393	+60%	+$15K	﹤0.01%	8614
2022 Q4	$15.6K	Buy	+657	New	+$16.6K	﹤0.01%	8661

Other funds holding ALGS

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jane Street's ALGS Position: Q2 2026 in Review

Jane Street opened a new position in Aligos Therapeutics (ALGS) in Q2 2026: 32,402 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #10176 among its holdings. This is a return to the name: Jane Street previously reported a position in ALGS as recently as Q4 2025.

Jane Street first reported a position in ALGS in Q4 2022 and has held it in 5 quarters since. The position peaked at $226K in Q4 2025. 31 funds tracked by Wall St. Rank hold ALGS as of Q2 2026.

Jane Street held 32,402 shares of Aligos Therapeutics worth $187K as of Q2 2026.
Aligos Therapeutics was a new Jane Street position in Q2 2026.
Aligos Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10176 holding.
Jane Street first reported a position in Aligos Therapeutics in Q4 2022 and has held it in 5 quarters since.
Jane Street's Aligos Therapeutics position peaked at $226K in Q4 2025.
31 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.